ICI shareholders approve demerger and flotation of Zeneca

Click to follow
The Independent Online
Sir Denys Henderson, ICI chairman, yesterday told shareholders that the best protection against a hostile takeover was performance 'helped by cost reductions and strategic positioning'. An extraordinary general meeting approved the demerger and flotation of ICI's Zeneca drugs arm.

(Photograph omitted)